Shoppers Drug Mart Given “Market Perform” Rating at BMO Capital Markets (SC)
Shoppers Drug Mart (TSE:SC)‘s stock had its “market perform” rating reiterated by investment analysts at BMO Capital Markets in a note issued to investors on Friday, StockRatingsNetwork reports. They currently have a C$58.50 price target on the stock, down from their previous price target of C$62.00. BMO Capital Markets’ target price points to a potential upside of 0.74% from the stock’s previous close.
Shoppers Drug Mart (TSE:SC) opened at 58.07 on Friday. Shoppers Drug Mart has a 52-week low of $41.46 and a 52-week high of $61.77. The stock has a 50-day moving average of $58.54 and a 200-day moving average of $59.35. The company has a market cap of $11.623 billion and a P/E ratio of 19.35.
Shoppers Drug Mart (TSE:SC) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.02. On average, analysts predict that Shoppers Drug Mart will post $3.00 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Canaccord Genuity cut their price target on shares of Shoppers Drug Mart from C$61.50 to C$59.00 in a research note to investors on Friday. Separately, analysts at TD Securities cut their price target on shares of Shoppers Drug Mart from C$64.00 to C$60.00 in a research note to investors on Tuesday, January 28th. They now have a “tender” rating on the stock. Finally, analysts at Desjardins cut their price target on shares of Shoppers Drug Mart from C$64.00 to C$62.55 in a research note to investors on Wednesday, November 13th. They now have a “hold” rating on the stock. Five research analysts have rated the stock with a hold rating, The stock has a consensus rating of “Hold” and an average target price of C$57.28.
Shoppers Drug Mart Corporation (TSE:SC) is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart (Pharmaprix in Quebec).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.